Common Antidepressant May Ease Long COVID's Crushing Fatigue The latest study from McMaster University and its collaborators offers a glimmer of hope for millions of people worldwide who are still struggling to recover from the debilitating effects of long COVID.
The finding that fluvoxamine, an inexpensive and widely available antidepressant, can significantly reduce fatigue and improve quality of life in adults with long COVID is a promising development.
Fatigue has been a persistent and disabling symptom for many people who have contracted SARS CoV 2. For some, it's a crushing exhaustion that interferes with daily activities, work, and family responsibilities.